Evidence method
Level · gp.fundamentals.debt_to_revenue
392.42% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
ANIP · Jun 30, 2020
ANI PHARMACEUTICALS INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001558370-20-009520General Corporate
Evidence method
Level · gp.fundamentals.capex_revenue_ratio
1.50% · OPTIONAL · VALID
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
43.08% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
-10.83% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
108.44% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
57.30% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
-23.33% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
6.26% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
11.83% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History49 statesSelf-history eligible
Sep 30, 20218/8 normalizedLevel 3Dec 31, 20218/8 normalizedLevel 3Mar 31, 20228/8 normalizedLevel 3Jun 30, 20228/8 normalizedLevel 3Sep 30, 20228/8 normalizedLevel 3Dec 31, 20228/8 normalizedLevel 3Mar 31, 20238/8 normalizedLevel 3Jun 30, 20238/8 normalizedLevel 3Sep 30, 20238/8 normalizedLevel 3Dec 31, 20238/8 normalizedLevel 3Mar 31, 20248/8 normalizedLevel 3Jun 30, 20248/8 normalizedLevel 3Sep 30, 20248/8 normalizedLevel 3Dec 31, 20248/8 normalizedLevel 3Mar 31, 20258/8 normalizedLevel 3Jun 30, 20258/8 normalizedLevel 3Sep 30, 20258/8 normalizedLevel 3Dec 31, 20258/8 normalizedLevel 3Mar 31, 20268/8 normalizedLevel 3Jun 30, 20268/8 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 401.75%
- Current
- 392.42%
- Delta
- -9.32%
- Previous
- 3.09%
- Current
- 1.50%
- Delta
- -1.60%
- Previous
- 3.44%
- Current
- 43.08%
- Delta
- 39.64%
- Previous
- -5.89%
- Current
- -10.83%
- Delta
- -4.94%
- Previous
- 106.28%
- Current
- 108.44%
- Delta
- 2.16%
- Previous
- 56.19%
- Current
- 57.30%
- Delta
- 1.11%
- Previous
- -15.76%
- Current
- -23.33%
- Delta
- -7.57%
- Previous
- 12.75%
- Current
- 6.26%
- Delta
- -6.48%
- Previous
- 4.87%
- Current
- 11.83%
- Delta
- 6.96%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · ANIP Fundamental State →Transitioned To · ANIP Fundamental State →Transitioned To · ANIP CAPEX_INTENSITY_DECREASED →Transitioned To · ANIP CASH_GENERATION_INCREASED →Transitioned To · ANIP GROWTH_DECREASED →Transitioned To · ANIP INVENTORY_PRESSURE_INCREASED →Transitioned To · ANIP MARGIN_INCREASED →Transitioned To · ANIP PROFITABILITY_DECREASED →Transitioned To · ANIP R_AND_D_INTENSITY_DECREASED →Transitioned To · ANIP SBC_INTENSITY_INCREASED →Transitioned To · ANIP BALANCE_SHEET_LEVERAGE_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.